Brief: Diffusion Pharmaceuticals Sends Letter To Stockholders

CervoMed

05/12/2022 11:54

Dec 5 (Reuters) - Diffusion Pharmaceuticals Inc
 DFFN.O :
    * DIFFUSION PHARMACEUTICALS SENDS LETTER TO STOCKHOLDERS
HIGHLIGHTING STRENGTH OF BOARD LEADERSHIP AND POSITIVE PROGRESS
IN STRATEGIC REVIEW, CAUTIONING STOCKHOLDERS REGARDING LIFESCI’S
HISTORY OF STOCKHOLDER VALUE DESTRUCTION AND SELF-DEALING
    * DIFFUSION PHARMACEUTICALS INC - RECEIVED BIDS FROM MORE
THAN 15
COMPANIES PARTICIPATING IN REVIEW PROCESS
    * DIFFUSION PHARMACEUTICALS INC - BOARD OF DIRECTORS URGES
STOCKHOLDERS TO VOTE "FOR" EACH OF ITS SIX NOMINEES FOR DIRECTOR
ON YOUR WHITE PROXY CARD
    * DIFFUSION PHARMACEUTICALS - URGES STOCKHOLDERS TO VOTE
"FOR"
EACH OF BOARD'S SIX NOMINEES FOR DIRECTOR ON WHITE PROXY CARD
    * DIFFUSION- REVIEWING RANGE OF POTENTIAL TRANSACTIONS THAT
WILL
LIKELY INVOLVE SIGNIFICANT CHANGES IN COMPOSITION OF BOARD,
INCLUDING A SALE OF COMPANY

Source text for Eikon:  ID:nGNXc0Mvj4 
Further company coverage:  DFFN.O